EUVIMEDEUVIMED entdecken
Crossref

DUSP6 Regulates Skin Inflammation, Parakeratosis and Disease Severity in a Murine Model of Psoriasis

Teresina Laragione, Carolyn Harris, Robert Phelps, Percio S Gulko iD

Experimental Dermatology · 2026-04 · 35 (4)

DOI: 10.1111/exd.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 08.04.2026. Verfasst von Teresina Laragione und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Psoriasis, Dual Specificity Phosphatase 6, Parakeratosis. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic inflammatory skin disease characterised by keratinocyte hyperproliferation and immune cell infiltration driven by cytokines such as IL‐17A. The dual‐specificity phosphatase 6 (DUSP6) is a negative regulator of MAPK signalling and was previously reported to be a key mediator of arthritis severity. Here, we examine the role of DUSP6 in a mouse model of psoriasis. Psoriasis was studied in the imiquimod‐induced model (IMQ). The skin of DUSP6+/+ and DUSP6−/− mice was treated with IMQ cream. Disease severity was assessed using well‐established clinical and histologic systems. Skin inflammatory genes were quantified by qPCR.DUSP6−/− mice exhibited significantly reduced skin inflammation with lower PASI clinical scores (mean DUSP6−/− 1.8 and DUSP6+/+ 8.4; p < 0.0001). Histologic scores for epidermal thickening, parakeratosis and immune cell infiltration were decreased in the DUSP6−/− mice ( p < 0.0005), and mRNA levels of IL1β, IL17A and STAT3 were lower in DUSP6−/− skin ( p ≤ 0.05) compared with DUSP6+/+. In conclusion, DUSP6 is required for the development of psoriasis‐like skin inflammation in mice. In the absence of DUSP6, mice were protected and had significantly lower levels of pathogenic genes, suggesting a new and central role for DUSP6 in skin inflammation and a potential therapeutic target in psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisDual Specificity Phosphatase 6ParakeratosisAnimalsDisease Models, AnimalMiceInterleukin-17Severity of Illness IndexImiquimodSTAT3 Transcription FactorMice, KnockoutSkinInterleukin-1betaInflammationMice, Inbred C57BL

Stichwörter der Autor:innen

autoimmunityinflammationmouse modelphosphatasepsoriasis

Substanzen

Dual Specificity Phosphatase 6Dusp6 protein, mouseInterleukin-17ImiquimodSTAT3 Transcription FactorStat3 protein, mouseInterleukin-1betaIl17a protein, mouseIL1B protein, mouse

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Dermatology and Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Percio S Gulko

Zitieren

APA

Laragione, T., Harris, C., Phelps, R., & Gulko, P. S. (2026). DUSP6 Regulates Skin Inflammation, Parakeratosis and Disease Severity in a Murine Model of Psoriasis. Experimental Dermatology, 35(4). https://doi.org/10.1111/exd.70245

Vancouver

Laragione T, Harris C, Phelps R, Gulko PS. DUSP6 Regulates Skin Inflammation, Parakeratosis and Disease Severity in a Murine Model of Psoriasis. Experimental Dermatology. 2026;35(4). doi:10.1111/exd.70245

BibTeX
@article{Laragione2026,
  author = {Laragione, Teresina and Harris, Carolyn and Phelps, Robert and Gulko, Percio S},
  title = {DUSP6 Regulates Skin Inflammation, Parakeratosis and Disease Severity in a Murine Model of Psoriasis},
  journal = {Experimental Dermatology},
  year = {2026},
  volume = {35},
  number = {4},
  doi = {10.1111/exd.70245}
}
Kostenlos starten →